B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells

Medicine & Life Sciences

• Regulatory T-Lymphocytes 91%
• Genetic Therapy 85%
• B-Lymphocytes 70%
• Antigens 58%
• Ovalbumin 51%
• OVA 323-339 43%
• Cell- and Tissue-Based Therapy 43%
• T-Lymphocytes 42%
• 6-carboxyfluorescein 32%
• CD4 Antigens 29%
• Hemophilia A 25%
• Esters 23%
• T-Cell Antigen Receptor 23%
• Antibody Formation 20%
• Transgenic Mice 20%
• Autoimmune Diseases 19%
• Animal Models 16%
• Lymphocytes 15%
• Cell Proliferation 15%
• Peptides 14%
• Phenotype 13%
• Animals 11%
• In Vitro Techniques 10%
• Population 8%

Chemistry

• Effector 100%
• Dilution 37%
• Ester 27%
• Peptide 26%